Yin-Chun Ji - State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai Inst Mat Med

基本信息

浏览量：43

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 57 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Design, synthesis, and structure-activity relationship studies of 6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazole derivatives as necroptosis inhibitors 后印本

Jin Zechen, Dai Yang,Ji Yinchun,Peng Xia, Duan Wenhu, Ai Jing, Zhang Hefeng

RSC MEDICINAL CHEMISTRY (2024)

引用0浏览0引用

Design, Synthesis, and Structure-Activity Relationship Studies of 6,7-Dihydro-5h-pyrrolo[1,2-b][1,2,4]triazole Derivatives As Necroptosis Inhibitors

Zechen Jin,Yang Dai,Yinchun Ji,Xia Peng,Wenhu Duan,Jing Ai,Hefeng Zhang

RSC MEDICINAL CHEMISTRYno. 7 (2024): 2514-2526

引用0浏览0WOS引用

Discovery and Optimization of 3-(Indolin-5-yloxy)pyridin-2-amine Derivatives As Potent Necroptosis Inhibitors

Yaohan Lan,Yinchun Ji,Xia Peng,Wenhu Duan,Meiyu Geng,Jing Ai,Hefeng Zhang

Archiv der Pharmazie（2024）

引用0浏览0WOS引用

Incorporation of a Rigid 1,3-Diketone-containing Fragment Led to Significantly Improved AXL Inhibitory Activity: Design, Synthesis, and SAR of the Anilinopyrimidine AXL Inhibitors

Wenyi Hu,Xia Peng,Yinchun Ji,Wenhu Duan,Jing Ai,Zhengsheng Zhan

Molecular Diversitypp.1-17, (2024)

引用0浏览0WOS引用

Remodeling Tumor‐associated Macrophage for Anti‐cancer Effects by Rational Design of Irreversible Inhibition of Mitogen‐activated Protein Kinase‐activated Protein Kinase 2

Danyi Wang,Deqiao Sun,Xiaoyan Wang,Xia Peng,Yinchun Ji, Lu Tang, Qichang He,Danqi Chen,Ye Yang, Xuan Zhou,Bing Xiong,Jing Ai

MedCommno. 7 (2024)

引用0浏览0WOS引用

Discovery, Optimization, and Evaluation of Novel Pyridin-2(1H)-one Analogues As Potent TRK Inhibitors for Cancer Treatment

Zichao Xu,Xia Peng,Renjie Zhang,Yinchun Ji, Mengke You,Danyi Wang,Yanyan Shen,Mingyue Zheng,Chunpu Li,Jing Ai,Hong Liu

Journal of Medicinal Chemistryno. 2 (2024): 1168-1183

引用1浏览0WOS引用

Synthesis and Evaluation of Hybrid Molecules As RIPK1 and HDACs Dual Inhibitors

Mingze Tang, Xuan Zhou,Qianqian Shen,Chen Fang,Xia Peng,Yinchun Ji, Guijun Zhu,Meiyu Geng,Yi Chen,Wenhu Duan,Jing Ai,Hefeng Zhang

Journal of Molecular Structure (2024): 139238-139238

引用0浏览0引用

Supplementary Materials and Methods; Tables S1-S4; Figures S1-S2 from Preclinical Evaluation of SCC244 (glumetinib), a Novel, Potent, and Highly Selective Inhibitor of C-Met in MET-dependent Cancer Models

Jing Ai,Yi Chen, Xia Peng,Yinchun Ji, Yong Xi,Yanyan Shen,Xinying Yang,Yi Su, Yiming Sun,Yinglei Gao,Yuchi Ma,Bing Xiong,Jingkang Shen,Jian Ding,Meiyu Geng

openalex（2023）

引用0浏览0引用

Discovery of a 1,6-Naphthyridin-4-one-based AXL Inhibitor with Improved Pharmacokinetics and Enhanced in Vivo Antitumor Efficacy

Yaohan Lan,Xia Peng,Yinchun Ji,Yi Su,Wenhu Duan,Jing Ai,Hefeng Zhang

European Journal of Medicinal Chemistry (2023): 116045-116045

引用1浏览0WOS引用

Structure-based Drug Discovery of Novel Fused-Pyrazolone Carboxamide Derivatives As Potent and Selective AXL Inhibitors

Feifei Fang,Yang Dai,Hao Wang,Yinchun Ji,Xuewu Liang,Xia Peng,Jiyuan Li, Yangrong Zhao,Chunpu Li,Danyi Wang,Yazhou Li,Dong Zhang,Dan Zhang,Meiyu Geng,Hong Liu,Jing Ai,Yu Zhou

ACTA PHARMACEUTICA SINICA Bno. 12 (2023): 4918-4933

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn